Prevalence and clinical features of colonic diverticulosis in a Middle Eastern population

Table 2 Comorbidities of patients and indications for a colonoscopy stratified by the presence and absence of diverticulosis as well as the univariable analysis between the presence of diverticulosis and the corresponding variables

Variable	Diverticulosis	No diverticulosis	P-value	Univariable analysis
				OR	95%CI
Comorbidities
Hypertension	63.88%	25.92%	< 0.01	5.05	3.06-8.34
Diabetes	44.44%	24.32%	< 0.01	2.49	1.53-4.05
Dyslipidemia	22.22%	10.77%	0.03	2.37	1.31-4.27
Aspirin	21.33%	9.23%	0.01	2.67	1.48-4.81
Chronic kidney disease	5.56%	3.12%	0.38	2.91	0.82-10.29
Coronary artery disease	4.16%	1.43%	0.27	1.82	0.62-5.30
Indication for colonoscopy
Bleeding per rectum	33.60%	22.08%	< 0.01	1.79	1.35-2.35
Abdominal pain	19.30%	15.20%	0.06	0.73	0.51-1.05
Constipation	12.80%	9.31%	0.11	1.43	0.96-2.11
Surveillance	10.40%	16.72%	< 0.01	0.58	0.38-0.87
Screening	6.40%	7.67%	0.43	0.82	0.49-1.39
Anemia	6.00%	4.94%	0.5	1.23	0.71-2.12
Melena	3.13%	4.40%	0.31	1.47	0.78-2.79
Diarrhea	2.40%	9.28%	< 0.01	0.24	0.11-0.55
Altered bowel habits	2.00%	1.74%	0.78	1.15	0.46-2.90
Weight loss	2.00%	5.79%	< 0.01	0.33	0.14-0.82
Anal pain	1.20%	1.97%	0.29	0.6	0.19-1.94
Positive for occult blood	1.20%	0.46%	0.29	2.62	0.75-9.19
Perianal fistula	0.40%	1.25%	0.06	0.32	0.04-2.32